Elder Project Ltd has been delisted from the stock exchange.
Sector
PharmaceuticalsOpen
₹20.15Prev. Close
₹20.15Turnover(Lac.)
₹0.01Day's High
₹20.15Day's Low
₹20.1552 Week's High
₹052 Week's Low
₹0Book Value
₹-11.42Face Value
₹10Mkt Cap (₹ Cr.)
6.51P/E
0EPS
0Divi. Yield
0No Record Found
No Record Found
| Y/e 31 Mar( In .Cr) | Jun-2013 | Mar-2012 | Mar-2011 | Mar-2010 |
|---|---|---|---|---|
Equity Capital | 3.23 | 3.23 | 3.23 | 3.23 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | -1.61 | -1.27 | -1.32 | -1.29 |
Net Worth | 1.62 | 1.96 | 1.91 | 1.94 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Jun-2013 | Mar-2012 | Mar-2011 |
|---|---|---|---|
Revenue | 6.38 | 9.77 | 8.75 |
yoy growth (%) | -34.65 | 11.62 | |
Raw materials | 0 | -1.32 | -1.21 |
As % of sales | 0 | 13.57 | 13.91 |
Employee costs | -1.65 | -1.52 | -1.29 |
| Y/e 31 Mar( In .Cr) | Jun-2013 | Mar-2012 | Mar-2011 |
|---|---|---|---|
Profit before tax | -0.27 | 0.29 | 0.05 |
Depreciation | -0.59 | -0.6 | -0.57 |
Tax paid | -0.05 | -0.24 | -0.06 |
Working capital | -1 | 1.89 | |
Other operating items |
| Y/e 31 Mar | Jun-2013 | Mar-2012 | Mar-2011 |
|---|---|---|---|
Growth matrix (%) | |||
Revenue growth | -34.65 | 11.62 | |
Op profit growth | -30.05 | 6.6 | |
EBIT growth | -22.48 | 35.83 | |
Net profit growth | -713.66 | -263.52 |
No Record Found
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,787.1 | 142.85 | 4,28,785.15 | 608.7 | 0.9 | 4,887.27 | 93.23 |
Divis Laboratories Ltd DIVISLAB | 6,638.9 | 66.2 | 1,76,241.94 | 756 | 0.45 | 2,793 | 629.49 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 4,463.3 | 68.28 | 1,51,058.35 | 467 | 0.85 | 2,677 | 249.73 |
Cipla Ltd CIPLA | 1,376.25 | 32.3 | 1,11,179.71 | 384.64 | 0.94 | 3,840.92 | 423.36 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,097.9 | 29.92 | 1,10,474.43 | 1,722 | 0.09 | 3,564.6 | 235.25 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman
Anuj Saxena
Director
Alok Saxena
Director
Jagat Varma
Director
Ravani Mohammed Abdul Khader
Director
Kader Mohammed Davawala
P No A-38/1 Patalganaga Indl A,
Village Khaire Taluka Khalapur,
Maharashtra - 410220
Tel: 91-2192-250020
Website: http://www.elderindia.com
Email: -
19/20 Jaferbhoy Ind,
1st Floor Makwana Rd, Marol Naka,
Mumbai - 400 059
Tel: 022 - 42270400
Website: www.adriotcorporate.com
Email: info@adroitcorporate.com
Summary
Elder Projects Limited manufactures injectibles in ampoules dosage form on contract basis in India. It also operates a restaurant. The company was incorporated in 1985 and it belongs to the Elder Grou...
Read More
Reports by Elder Project Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.